ISMRM 25th Annual Meeting & Exhibition • 22-27 April 2017 • Honolulu, HI, USA
|Sunrise Educational Session: Imaging Tumor Response to Therapy|
ORGANIZERS: Linda Moy, M.D. & Valeria Panebianco, M.D.
Thursday, 27 April 2017
Skill Level: Intermediate
Slack Channel: #e_cancer_mol_mrs
Session Number: STh07
Several subtypes of breast cancer and gynecological cancers have been identified. Tailored therapies have been developed to treat the more aggressive subtypes of these cancers. It is important to understand the role of MRI in assessing response to these tailored treatment regimens.
Attendees who are interested in breast and gynecological malignancies will benefit from this course. In addition, attendees interested in differentiating inflammatory changes from treatment versus tumors that are unresponsive to this targeted chemotherapy should attend this course.
Upon completion of this course, participants should be able to:
-Understand the increasingly important role of neoadjuvant therapy in certain subtypes of breast and gynecological cancers;
-Understand the role of anti-hormonal agents in breast and gynecological malignancies; and
-Assess the role of MRI in the management of response to different therapies.
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for